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Abstract 
Review on t(11;16)(q23;q24), with data on clinics, 
and the genes involved. 
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Figure 1. Partial karyogram representing the 
t(11;16)(q23;q24) (Zerkalenkova et al., 2018). Clinics and 
pathology 
Disease 
Acute monoblastic leukaemia (AML-M5a) 
Epidemiology 
Poorly defined, only one case described to date, a 
15 years-old boy with AML-M5a relapse 
(Zerkalenkova et al., 2018). 
Treatment 
The patient was treated according to AML-BFM-
2004 protocol and remission was achieved after the 
2nd induction course.  
After two years a bone marrow relapse of AML M5a 
was diagnosed. 
Prognosis 
The prognosis was poor, the current patient died due 




MLL dual color break apart rearrangement probe. 
Additional anomalies 
del(7p) 
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Figure 2. The probe was hybridized to metaphase and displayed 3'-portion of KMT2A translocated to chromosome 16 
(Zerkalenkova et al., 2018). 
 
Genes involved and 
proteins 




KMT2A gene consists of 37 exons encoding a 3969 
amino-acid nuclear protein with a molecular weight 
of nearly 431 kDa. 
Protein 
431 kDa; contains two DNA binding motifs (a AT 
hook and Zinc fingers), and a DNA methyl 
transferase motif; wide expression; nuclear 
localization; transcriptional regulatory factor. 




USP10 gene consists of 14 exons encoding a 798 
amino-acid protein with a molecular weight of 
87134 Da. 
Protein 
87134 Da; belongs to the ubiquitin-specific 
proteases family; contains N-terminal thiol 
hydrolase catalytic domain and C-terminal Ataxin-2 
extension that mediates protein-protein interactions; 
widely expressed; found in nucleus, cytoplasm and 
early endosomes; deubiquitinates various substrates. 
Main substrate: TP53. Upon DNA damage USP10 
moves to nucleus where deubiquitinates the p53 
protein thus increasing p53 levels (Yuan et al., 
2010). 
 
Result of the chromosomal 
anomaly 
Hybrid gene 
KMT2A/USP10 fusion gene was detected by LDI-




KMT2A/USP10 fusion gene contains 5'-portion of 
KMT2A and 3'-portion of USP10. Breakpoints are 
localized in KMT2A intron 12 and USP10 intron 1. 
Fusion protein 
Description 
KMT2A/USP10 fusion protein joins amino-acid 
residue 1493 of KMT2A to amino-acid residue 8 of 
USP10 thus retaining KMT2A AT hooks, Pro-rich, 
and the Zn finger CXXC type domains and almost 
entire USP10. 
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